Antibiotics and reagents
The following antibiotics and reagents were purchased from commercial sources : ampicillin, cefoxitin, cefotaxime, streptomycin and penicillinase (PCase) from Bacillus cereus (Sigma, St. Louis, MO, USA) ; imipenem (USP Rockville, MD, USA) ; clavulanate (Wako Pure Chemical Industries Ltd.) and mtrocefin (Oxoid, Basingstoke, UK).
Antibiotic susceptibility testing
The susceptibility of bacteria to various antibiotics is expressed as their minimum inhibition concentrations (MICs). MICs of antibiotics were determined by the broth microdilution method in cation-adjusted Mueller-Hinton (MH) broth, based on the guidelines of NCCLS21).
Detection o f bla genes bla genes were detected by PCR analysis. Specific primers for blaIMP, blaSME, blaTEM and blaSHV were designed as previously reported 22-24) and are listed in Table 1 . Table 2 . Antibiotic susceptibility * , R : Resistant ; I : Intermediate ; S : Susceptible Fig. 1 . PCR analysis of the presence of bla genes. Lane M, 100 by DNA Ladder ; Lane SM2, a strain bearing the blarEM gene ; Lane SM7, a strain bearing both the blaimp and blaiEM genes ; Lane SM19, a strain bearing the blaimp gene ; Lane SM22, a strain for negative control.
Results

S. marcescens SM19, a clinical isolate from one patient with multiple infections
Six strains of bacteria, S. marcescens (SM19), P. aeruginosa, S. maltophilia, Pseudomonas spp., Non-Fermenter spp. and Corynebacterium spp. were simultaneously isolated by aerobic culture of the urine specimen from one patient. The susceptibilities of these bacteria to antimicrobial agents are listed in Table 2 . SM19 showed super-resistance to multiple antimicrobial agents. P. aeruginosa, S. maltophilia, Pseudomonas spp. and Non-Fermenter spp. also showed resistance to some antimicrobial agents.
Failure to transfer the blaimp gene carried by SM19 SM19 expressed a bla,MP gene, which was confirmed by PCR analysis (Fig. 1) . Transfer of the blaimp gene was attempted by conjugation and transformation using E. coli HB101 and E. coli JM109 as the recipient cells, respectively. As controls, the blaTEM gene in SM2 and the blaIMP / blaTEM genes in SM7 were easily transferred by both conjugation and transformation. The frequency of the gene transfer was 10-4 by conjugation, and 10-s by transformation.
However, unlike the controls and other S. marcescens strains we tested 20) , the blaIMP gene from SM19 could not be transferred by either conjugation or transformation ( strains, and even across species. In the clinical isolates of imipenem-resistant S. marcescens we observed, the plasmid with both blaIMP and blaTEM genes or with blaTEM gene alone could be easily transferred20). However, the blaIMP gene carried by SM19 could not be transferred to other bacterial strains by either conjugation or transformation via electroporation, suggesting the possibility of multiple locations of the blame gene on both the plasmid and the chromosome in various strains of S. marcescens. Further experiments are needed to identify the exact location (s) of the gene. As a super-resistant strain of S. marcescens, SM19 showed high resistance not only to all of the a-lactams used in the clinical setting, but also to various inhibitors of protein synthesis, such as aminoglycosides (amikacin, streptomycin), tetracycline and chloramphenicol, and inhibitors of nucleic acid synthesis, such as ofloxacin. Modifications of enzymes, mutations of rRNA and efflux systems have been reported as the mechanisms of bacterial resistance against such agents. Nevertheless, how one strain can obtain so many resistant factors is still unknown.
P. aeruginosa is a major human pathogen in the pseudomonas group and is resistant naturally to many antimicrobial agents. S. maltophilia is also an increasing cause of hospital-acquired infections in immuno-compromised patients. In the case of this report, S. marcescens, P. aeruginosa, S. maltophilia, Pseudomonas spp., Non-Fermenter spp. and Corynebacterium spp. were isolated from the same urine specimen. We propose that the simultaneous presence of multiple species of bacteria resistant to antibiotics in one patient might be one of the reasons of the appearance of such a super-resistant S. marcescens SM19. [Received January 23, 2007 : Accepted February 2, 2007 
